Iktos raises €15.5M to expand AI drug discovery technologies
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a…
March 9, 2023 - 2 minutes
Peptides
Korean researchers develop antimicrobial peptides discovery tool
Antimicrobial peptides (AMPs) are a promising new weapon for combating the growing antimicrobial resistance (AMR)…
February 23, 2023 - 3 minutes
Cytovation melanoma study under way
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its…
February 16, 2023 - 2 minutes
IMV presents positive lymphoma trial results
IMV Inc. has announced positive preliminary data from its VITALIZE phase 2B trial. The study…
February 14, 2023 - 3 minutes
New method to design new peptide therapeutics
Researchers at Hokkaido University in Japan have developed a novel method to design and develop…
February 9, 2023 - 3 minutes
Orbit Discovery and Endevica Bio to develop cachexia therapeutics
Orbit Discovery Limited has entered into a multi target research agreement with Endevica Bio Inc. …
February 2, 2023 - 3 minutes
New tool to fight antibiotic resistance
The World Health Organization (WHO) ranks antibiotic resistance as one of the top 10 threats…
January 26, 2023 - 5 minutes
Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs
Orbit Discovery Limited has entered into a master service agreement with SanegeneBio Inc., a start-up…
January 6, 2023 - 2 minutes
Funding to develop wearable patch for type 2 diabetes
A project to develop a patch worn on the cheek that delivers peptide treatments for…
November 23, 2022 - 4 minutes
Migraines: a new vaccine frontier beyond infectious diseases
By bringing the efficiency and affordability of vaccines to chronic diseases such as migraines, U.S.…
October 28, 2022 - 7 minutes
Enterome presents more data on therapeutic cancer treatment
Clinical stage biopharma company Enterome has presented new data from its two phase 1/2 clinical…
September 12, 2022 - 3 minutes
Alume Biosciences progressing with fluorescence study in patients undergoing head and neck surgery
Alume Biosciences, Inc. says the first patient has been dosed in a phase 3 pivotal…
August 23, 2022 - 2 minutes
